PURPOSE: The goal of this study was to evaluate disease, survival, and toxic effects after unilateral radiation therapy treatment for tonsillar cancer. METHODS AND MATERIALS: A retrospective study was performed of patients treated at our institution within the period from 2000 to 2018. Summary statistics were used to assess the cohort by patient characteristics and treatments delivered. The Kaplan-Meier method was used to determine survival outcomes. RESULTS: The cohort comprised 403 patients, including 343 (85%) with clinical and/or radiographic evidence of ipsilateral cervical nodal disease and 181 (45%) with multiple involved nodes. Human papillomavirus was detected in 294 (73%) tumors. Median follow-up time was 5.8 years. Disease relapse was infrequent with local recurrence in 9 (2%) patients, neck recurrence in 13 (3%) patients, and recurrence in the unirradiated contralateral neck in 9 (2%) patients. Five- and 10-year overall survival rates were 94% and 89%, respectively. Gastrostomy tubes were needed in 32 (9%) patients, and no patient had a feeding tube 6 months after therapy. CONCLUSIONS: For patients with well-lateralized tonsillar tumors and no clinically evident adenopathy of the contralateral neck, unilateral radiation therapy offers favorable rates of disease outcomes and a relatively low toxicity profile.
PURPOSE: The goal of this study was to evaluate disease, survival, and toxic effects after unilateral radiation therapy treatment for tonsillar cancer. METHODS AND MATERIALS: A retrospective study was performed of patients treated at our institution within the period from 2000 to 2018. Summary statistics were used to assess the cohort by patient characteristics and treatments delivered. The Kaplan-Meier method was used to determine survival outcomes. RESULTS: The cohort comprised 403 patients, including 343 (85%) with clinical and/or radiographic evidence of ipsilateral cervical nodal disease and 181 (45%) with multiple involved nodes. Human papillomavirus was detected in 294 (73%) tumors. Median follow-up time was 5.8 years. Disease relapse was infrequent with local recurrence in 9 (2%) patients, neck recurrence in 13 (3%) patients, and recurrence in the unirradiated contralateral neck in 9 (2%) patients. Five- and 10-year overall survival rates were 94% and 89%, respectively. Gastrostomy tubes were needed in 32 (9%) patients, and no patient had a feeding tube 6 months after therapy. CONCLUSIONS: For patients with well-lateralized tonsillar tumors and no clinically evident adenopathy of the contralateral neck, unilateral radiation therapy offers favorable rates of disease outcomes and a relatively low toxicity profile.
Authors: B O'Sullivan; P Warde; B Grice; C Goh; D Payne; F F Liu; J Waldron; A Bayley; J Irish; P Gullane; B Cummings Journal: Int J Radiat Oncol Biol Phys Date: 2001-10-01 Impact factor: 7.038
Authors: Shao Hui Huang; John Waldron; Scott V Bratman; Jie Su; John Kim; Andrew Bayley; John Cho; Meredith Giuliani; Andrew Hope; Jolie Ringash; Aaron Hansen; John R de Almeida; David Goldstein; Bayardo Perez-Ordonez; Ilan Weinreb; Li Tong; Wei Xu; Brian O'Sullivan Journal: Int J Radiat Oncol Biol Phys Date: 2017-01-09 Impact factor: 7.038
Authors: Anamaria Reyna Yeung; Madhur Kumar Garg; Joshua Lawson; Mark W McDonald; Harry Quon; John A Ridge; Nabil Saba; Joseph K Salama; Richard V Smith; Sue S Yom; Jonathan J Beitler Journal: Head Neck Date: 2012-01-17 Impact factor: 3.147
Authors: Jessika A Contreras; Christopher Spencer; Todd DeWees; Bruce Haughey; Lauren E Henke; Re-I Chin; Randal Paniello; Jason Rich; Ryan Jackson; Peter Oppelt; Patrik Pipkorn; Jose Zevallos; Rebecca Chernock; Brian Nussenbaum; Mackenzie Daly; Hiram Gay; Douglas Adkins; Wade Thorstad Journal: J Clin Oncol Date: 2019-06-27 Impact factor: 44.544
Authors: Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Asher Lisec; Clare P Alvarez; Dianna B Roberts; Stephen Y Lai; Jan S Lewin Journal: Head Neck Date: 2013-01-16 Impact factor: 3.147
Authors: Nicolette Taku; Li Wang; Adam S Garden; David I Rosenthal; G Brandon Gunn; William H Morrison; C David Fuller; Jack Phan; Jay P Reddy; Amy C Moreno; Michael T Spiotto; Gregory Chronowski; Shalin J Shah; Lauren L Mayo; Neil D Gross; Renata Ferrarotto; X Ronald Zhu; Xiaodong Zhang; Steven J Frank Journal: Curr Treat Options Oncol Date: 2021-06-04
Authors: Kaitlin M Christopherson; Amy C Moreno; Baher Elgohari; Neil Gross; Renata Ferrarotto; Abdallah Sherif Radwan Mohamed; G Brandon Gunn; Ryan P Goepfert; Frank E Mott; Shalin J Shah; C David Fuller; Jay P Reddy; Steven J Frank; William H Morrison; Jack Phan; David I Rosenthal; Adam S Garden Journal: Oral Oncol Date: 2020-12-22 Impact factor: 5.972